GENE ONLINE|News &
Opinion
Blog

Multiple Sclerosis
Genentech Takes Biogen to Court Over Stockpiled Multiple Sclerosis Drug Royalties
2023-03-01
TG Notches FDA Victory For CD20 Antibody For Multiple Sclerosis
2022-12-29
US Court Rules Novartis Blockbuster Multiple Sclerosis Drug’s Patent Invalid
2022-06-22
Janssen’s Multiple Sclerosis Drug Snags FDA Win after Besting Sanofi’s Blockbuster in Phase 3
2021-03-21
Biogen Strengthens its Grip on the Multiple Sclerosis Market with Another FDA Approval
2021-02-02
Novartis’ Kesimpta Notches FDA Approval as Targeted B-cell Therapy for Patients with Relapsing MS
2020-08-23
Sanofi Advances in Multiple Sclerosis Market with Principia Acquisition Deal
2020-08-18
Novartis Wins Five Simultaneous Drug Approvals in Japan
2020-07-06
Novartis Reveals Positive Ofatumumab Data for Treating Relapsing Forms of Multiple sclerosis
2020-06-07
Breakthrough Stem Cell Therapy Research Shows Repair in Multiple Sclerosis Damage
2020-05-24
Novartis Announces Mayzent Data that Shows Extended Benefit in Secondary Progressive MS
2020-04-21
Sanofi’s BTK Inhibitor Meets Primary Endpoint in Phase 2 Trial Amidst Criticism
2020-02-07
LATEST
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
Kate Middleton, Princess of Wales: Cancer Journey and Recovery
2025-01-15
What is Tech Giant NVIDIA Doing Now? Latest Collabs Building the Healthcare Puzzle, One Byte at a Time
2025-01-15
EY Predicts Smarter, Smaller M&A in Biotech and Pharma for 2025
2025-01-15
EVENT
2025-01-13
JP Morgan Healthcare Conference
San Francisco, California
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
Scroll to Top